RSS Atom • ISSN 1472-4683 • Subscribe • About
PK and drug interactions
- 13th International workshop on Clinical Pharmacology of HIV Therapy 16–18 April 2012, Barcelona Conference reports - PK and drug interactions - PK Workshop 13th 2012 - 1 May 2012
- Studies on pipeline ARVs: Quad, evitegravir/cobicistat, cobisistat, GSK1265744, BMS986001 dolutegravir, GSK-1265744, long acting formulations (monthly injections): rilpivirine-LA, raltegravir and patient views Conference reports - PK and drug interactions - PK Workshop 13th 2012 - 1 May 2012
- Washout pharmacokinetics of transplacental raltegravir in neonates Conference reports - PK and drug interactions - PK Workshop 13th 2012 - 1 May 2012
- Interactions between malaria drugs and etravirine or darunavir/r Conference reports - PK and drug interactions - PK Workshop 13th 2012 - 1 May 2012
- No interaction between antimalarial amodiaquine and nevirapine Conference reports - PK and drug interactions - PK Workshop 13th 2012 - 1 May 2012
- Atazanavir/ritonavir and voriconazole not to be coadministered Conference reports - PK and drug interactions - PK Workshop 13th 2012 - 1 May 2012
- Milk thistle (silymarin) and darunavir/ritonavir Conference reports - PK and drug interactions - PK Workshop 13th 2012 - 1 May 2012
- Echinacea and etravirine Conference reports - PK and drug interactions - PK Workshop 13th 2012 - 1 May 2012
- Warfarin and ARVs: impact of African American race and ritonavir Conference reports - PK and drug interactions - PK Workshop 13th 2012 - 1 May 2012
- Case reports of complications from ketamine use in two MSM on ritonavir-based combinations Conference reports - PK and drug interactions - BHIVA 18th Birmingham 2012 - 1 May 2012
- Intranasal and topical corticosteroids and risk of Cushing’s symptoms in HIV patients on ritonavir-based combinations Conference reports - PK and drug interactions - Side effects - BHIVA 18th Birmingham 2012 - 1 May 2012
- FDA warning of drug interactions between boceprevir and some HIV protease inhibitors PK and drug interactions - 1 April 2012
- Interactions between nevirapine and antimalarials (artemether and lumefantrine) PK and drug interactions - 1 February 2012
- Interactions between antiretrovirals and complementary and African traditional medicines PK and drug interactions - 1 February 2012
- Contraceptive failure with etonogestrel implants and efavirenz: case reports PK and drug interactions - 1 February 2012
- Higher plasma levels of tenofovir and darunavir but not efavirenz in older patients Conference reports - PK and drug interactions - EACS 13 Belgrade 2011 - 1 December 2011
- Ritonavir levels reduced with high fat meal Conference reports - Nutrition - PK and drug interactions - EACS 13 Belgrade 2011 - 1 December 2011
- Monitoring kidney function change with cobicistat Conference reports - PK and drug interactions - ICAAC 51th Chicago 2011 - 1 December 2011
- Pharmacokinetics of darunavir and fosamprenavir in pregnancy Conference reports - PK and drug interactions - PMTCT and maternal health - IAS 6 Rome 2011 - 1 August 2011
- Dolutegravir (S/GSK1349572) with multivitamins or acid reducing agents PK and drug interactions - 1 August 2011
- Lopinavir and rifampicin interaction in HIV-positive patients PK and drug interactions - 1 August 2011
- Case Reports – Cushing’s syndrome with atazanavir/ritonavir PK and drug interactions - 1 August 2011
- Pharmacokinetics of different rifabutin dosing strategies with lopinavir/ritonavir-based ART Conference reports - PK and drug interactions - TB coinfection - CROI 18 (Retrovirus) 2011 - 1 August 2011
- Case report: extreme bradycardia with lopinavir/ritonavir and metoprolol and lacidipine PK and drug interactions - 1 April 2011
- Pharmacokinetics of lopinavir/ritonavir in combination with rifampicin based TB treatment in children Conference reports - PK and drug interactions - Paediatric care - TB coinfection - HIV 10 Glasgow 2010 - 1 December 2010
- Higher risk of potential drug-drug interactions in HIV patients over 60 Conference reports - PK and drug interactions - HIV and Ageing Baltimore 2010 - 1 December 2010
- Smoking and atazanavir levels Conference reports - PK and drug interactions - World AIDS 18 Vienna 2010 - 26 August 2010
- Darunavir/ritonavir and rosuvastatin Conference reports - PK and drug interactions - World AIDS 18 Vienna 2010 - 26 August 2010
- Case report – lack of PK interaction between bosentan and nevirapine PK and drug interactions - 26 August 2010
- Pharmacokinetics of once daily darunavir/ritonavir and efavirenz PK and drug interactions - 26 August 2010
- 11th International Workshop on Clinical Pharmacology of HIV Therapy, 7-9 April, 2010, Sorrento, Italy Conference reports - PK and drug interactions - Conference index - PK Workshop 11th 2010 - 1 June 2010
- Atazanavir absorption maximised with food Conference reports - PK and drug interactions - PK Workshop 11th 2010 - 1 June 2010
- Methadone levels reduced moderately by rilpivirine Conference reports - PK and drug interactions - PK Workshop 11th 2010 - 1 June 2010
- Maraviroc 150mg once-daily achieves target concentrations with atazanavir/ritonavir Conference reports - PK and drug interactions - PK Workshop 11th 2010 - 1 June 2010
- Raltegravir and unboosted atazanavir Conference reports - PK and drug interactions - PK Workshop 11th 2010 - 1 June 2010
- Raltegravir dose adjustment not required for patients on dialysis Conference reports - PK and drug interactions - PK Workshop 11th 2010 - 1 June 2010
- Raltegravir and darunavir pharmacokinetics in liver disease Conference reports - PK and drug interactions - PK Workshop 11th 2010 - 1 June 2010
- Tenofovir may require closer renal monitoring in older patients Conference reports - Injecting drug users - PK and drug interactions - PK Workshop 11th 2010 - 1 June 2010
- Effect of age on atazanavir, darunavir, raltegravir and etravirine Conference reports - PK and drug interactions - PK Workshop 11th 2010 - 1 June 2010
- Proposed approach to measuring TDM for raltegravir Conference reports - PK and drug interactions - PK Workshop 11th 2010 - 1 June 2010
- Increased bilirubin levels when atazanavir is dosed twice-daily Conference reports - PK and drug interactions - PK Workshop 11th 2010 - 1 June 2010
- Poor bioequivalence with crushed and dissolved tablets Conference reports - PK and drug interactions - Paediatric care - CROI 17 (Retrovirus) 2010 - 1 June 2010
- No clinically relevant interactions between TMC278 and oral contraceptives (norethindrone plus ethinylestradiol) Conference reports - PK and drug interactions - Women's health - EACS 12 Cologne 2009 - 21 February 2010
- Pilot PK study of two generic paediatric formulations of lopinavir/ritonavir vs originator products Conference reports - PK and drug interactions - Paediatric care - EACS 12 Cologne 2009 - 21 February 2010
- Other selected PK and drug interaction summaries from EACS Conference reports - PK and drug interactions - EACS 12 Cologne 2009 - 21 February 2010
- No interaction between tipranavir/ritonavir and efavirenz PK and drug interactions - 8 February 2010
- Significant interactions between tipranavir/ritonavir and statins PK and drug interactions - 8 February 2010
- Summary of interactions between vivriviroc and other ARVs PK and drug interactions - 8 February 2010
- Significant interaction between atazanavir/ritonavir and the antipsychotic drug quetiapine PK and drug interactions - 8 February 2010
- Alcohol and marijuana may reduce drug levels of atazanavir and efavirenz Conference reports - PK and drug interactions - ICAAC 49th San Fransisco 2009 - 31 December 2009
- Other drug interaction studies at ICAAC Conference reports - PK and drug interactions - ICAAC 49th San Fransisco 2009 - 31 December 2009
- Reduced etravirine levels after direct switch from efavirenz PK and drug interactions - 30 December 2009
- Raltegravir trough levels reduced by etravirine may require use of TDM PK and drug interactions - 2 October 2009
- Lopinavir/r affects PK exposure of some antimalarial drugs PK and drug interactions - 2 October 2009
- Monotherapy study may explain previous poor clinical results when abacavir and tenofovir are used in combination Conference reports - PK and drug interactions - PK Workshop 10th 2009 - 23 August 2009
- Interactions between ARVs and antimalarials atovaquone and proguanil Conference reports - PK and drug interactions - PK Workshop 10th 2009 - 23 August 2009
- Efavirenz lowers levels of darunavir given as 900/100mg once daily with ritonavir Conference reports - PK and drug interactions - PK Workshop 10th 2009 - 3 June 2009
- Potential interactions between antiviral treatment for swine flu (H1N1) and anti-HIV therapy PK and drug interactions - 2 June 2009
- Case reports of significant interactions between etravirine and raltegravir PK and drug interactions - 2 June 2009
- Effect of tenofovir on abacavir phosphorylation Conference reports - PK and drug interactions - CROI 16 (Retrovirus) 2009 - 20 April 2009
- PI interactions: lopinavir/rifampicin, saquinavir, atazanavir/tenofovir in pregnancy Conference reports - PK and drug interactions - CROI 16 (Retrovirus) 2009 - 20 April 2009
- Interaction study of ketoconazole and ritonavir-boosted saquinavir PK and drug interactions - 20 April 2009
- Tipranavir/ritonavir interactions with clarithromycin, fluconazole and rifabutin PK and drug interactions - 20 April 2009
- Elvitegravir with tipranavir/ritonavir or darunavir/ritonavir PK and drug interactions - 9 February 2009
- Serum bilirubin increases when PEG-interferon and ribavirin are used with atazanavir PK and drug interactions - 9 February 2009
- Effect on tacrolimus when switching from nelfinavir to fosamprenavir PK and drug interactions - 9 February 2009
- Drug interaction studies with approved drugs Conference reports - PK and drug interactions - ICAAC 48th Washington 2008 - 26 December 2008
- Drug interaction reports from Liverpool University website PK and drug interactions - 30 October 2008
- Darunavir/ritonavir interaction with clarithromycin warrants caution PK and drug interactions - 1 February 2008
- Drug interaction studies presented at EACS Basic science and immunology - Conference reports - PK and drug interactions - EACS 11 Madrid 2007 - 1 December 2007
- New drug interaction summary tables: maraviroc, integrase inhibitors, etravirine, hormonal contraceptives PK and drug interactions - 1 December 2007